To access this element change to forms mode OFF
Grant Award View - GA352095
Change of G6PD activity in the course of malaria
GA ID:
GA352095
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
6-Nov-2023
Publish Date:
8-Jan-2024
Category:
Medical Research
Grant Term:
1-Mar-2024 to 28-Feb-2027
Value (AUD):
$1,290,151.02
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 22/23 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
Change of G6PD activity in the course of malaria
Purpose:
Malaria is a serious and potentially deadly disease. Following a first symptomatic phase, some malaria species develop asymptomatic forms that cause a second symptomatic phase weeks to months after the first episode. The drugs currently used to treat this malaria species can cause severe side effects in people with low activities of a particular enzyme (G6PD). This project will test whether G6PD levels increase during a malaria attack, rendering treatment much safer than what is assumed to date.
GO ID:
GO Title:
Ideas Grants 2023
InternalReferenceId:
2023/GNT2028979
Selection Process:
Open Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Menzies School of Health Research
Recipient ABN:
70 413 542 847
Grant Recipient Location
Suburb:
Tiwi
Town/City:
Tiwi
Postcode:
0810
State/Territory:
NT
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, NT
Postcode:
Multiple
Country:
AUSTRALIA